US Stock MarketDetailed Quotes

INmune Bio (INMB)

Watchlist
  • 1.700
  • 0.0000.00%
Close Jan 23 15:59 ET
  • 1.700
  • 0.0000.00%
Post 17:14 ET
45.19MMarket Cap-0.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INmune Bio (INMB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
257.14%50K
-90.97%14K
0
0
0
-63.16%14K
-58.56%155K
-71.13%28K
Operating revenue
--0
--0
257.14%50K
-90.97%14K
--0
--0
--0
-63.16%14K
-58.56%155K
-71.13%28K
Cost of revenue
Gross profit
Operating expense
-39.50%7.43M
-18.33%8.06M
-9.75%9.96M
42.66%42.65M
12.61%9.47M
43.34%12.29M
52.78%9.87M
70.73%11.03M
13.57%29.9M
46.49%8.41M
Selling and administrative expenses
14.74%2.55M
-19.88%2.25M
-0.94%2.32M
-1.45%9.48M
-11.92%2.11M
-14.19%2.22M
21.78%2.81M
0.43%2.34M
3.94%9.62M
3.05%2.4M
-General and administrative expense
14.74%2.55M
-19.88%2.25M
-0.94%2.32M
-1.45%9.48M
-11.92%2.11M
-14.19%2.22M
21.78%2.81M
0.43%2.34M
3.94%9.62M
3.05%2.4M
Research and development costs
-51.46%4.89M
-17.71%5.8M
-12.12%7.64M
63.60%33.17M
22.41%7.35M
68.20%10.07M
70.03%7.05M
110.33%8.69M
18.78%20.27M
76.16%6.01M
Operating profit
39.50%-7.43M
18.33%-8.06M
10.09%-9.91M
-43.35%-42.64M
-12.98%-9.47M
-44.07%-12.29M
-53.88%-9.87M
-71.52%-11.02M
-14.60%-29.74M
-48.51%-8.38M
Net non-operating interest income expense
Other net income (expense)
397.93%961K
-13,882.35%-16.4M
2,175.00%166K
307.12%553K
958.62%249K
651.43%193K
232.22%119K
92.92%-8K
80.19%-267K
84.82%-29K
Special income (charges)
--0
---16.51M
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
--0
--16.51M
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
397.93%961K
-5.04%113K
2,175.00%166K
307.12%553K
958.62%249K
651.43%193K
232.22%119K
92.92%-8K
80.19%-267K
84.82%-29K
Income before tax
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
Income tax
Net income
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
Net income continuous Operations
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
Minority interest income
Net income attributable to the parent company
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
Basic earnings per share
60.00%-0.24
-110.00%-1.05
29.51%-0.43
-26.35%-2.11
14.89%-0.4
-25.00%-0.6
-38.89%-0.5
-69.44%-0.61
-9.87%-1.67
-46.88%-0.47
Diluted earnings per share
60.00%-0.24
-110.00%-1.05
29.51%-0.43
-26.35%-2.11
14.89%-0.4
-25.00%-0.6
-38.89%-0.5
-69.44%-0.61
-9.87%-1.67
-46.88%-0.47
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 00257.14%50K-90.97%14K000-63.16%14K-58.56%155K-71.13%28K
Operating revenue --0--0257.14%50K-90.97%14K--0--0--0-63.16%14K-58.56%155K-71.13%28K
Cost of revenue
Gross profit
Operating expense -39.50%7.43M-18.33%8.06M-9.75%9.96M42.66%42.65M12.61%9.47M43.34%12.29M52.78%9.87M70.73%11.03M13.57%29.9M46.49%8.41M
Selling and administrative expenses 14.74%2.55M-19.88%2.25M-0.94%2.32M-1.45%9.48M-11.92%2.11M-14.19%2.22M21.78%2.81M0.43%2.34M3.94%9.62M3.05%2.4M
-General and administrative expense 14.74%2.55M-19.88%2.25M-0.94%2.32M-1.45%9.48M-11.92%2.11M-14.19%2.22M21.78%2.81M0.43%2.34M3.94%9.62M3.05%2.4M
Research and development costs -51.46%4.89M-17.71%5.8M-12.12%7.64M63.60%33.17M22.41%7.35M68.20%10.07M70.03%7.05M110.33%8.69M18.78%20.27M76.16%6.01M
Operating profit 39.50%-7.43M18.33%-8.06M10.09%-9.91M-43.35%-42.64M-12.98%-9.47M-44.07%-12.29M-53.88%-9.87M-71.52%-11.02M-14.60%-29.74M-48.51%-8.38M
Net non-operating interest income expense
Other net income (expense) 397.93%961K-13,882.35%-16.4M2,175.00%166K307.12%553K958.62%249K651.43%193K232.22%119K92.92%-8K80.19%-267K84.82%-29K
Special income (charges) --0---16.51M--------------0----------------
-Less:Impairment of capital assets --0--16.51M--------------0----------------
Other non- operating income (expenses) 397.93%961K-5.04%113K2,175.00%166K307.12%553K958.62%249K651.43%193K232.22%119K92.92%-8K80.19%-267K84.82%-29K
Income before tax 46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M
Income tax
Net income 46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M
Net income continuous Operations 46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M
Minority interest income
Net income attributable to the parent company 46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M
Basic earnings per share 60.00%-0.24-110.00%-1.0529.51%-0.43-26.35%-2.1114.89%-0.4-25.00%-0.6-38.89%-0.5-69.44%-0.61-9.87%-1.67-46.88%-0.47
Diluted earnings per share 60.00%-0.24-110.00%-1.0529.51%-0.43-26.35%-2.1114.89%-0.4-25.00%-0.6-38.89%-0.5-69.44%-0.61-9.87%-1.67-46.88%-0.47
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.28%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.74%
4
Amazon
AMZN
+2.06%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.18%
Sample Name
Sample Code
 +8.06%
Sample Name
Sample Code
 +4.49%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.59%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -